Bird Matthew J, Needham Karina, Frazier Ann E, van Rooijen Jorien, Leung Jessie, Hough Shelley, Denham Mark, Thornton Matthew E, Parish Clare L, Nayagam Bryony A, Pera Martin, Thorburn David R, Thompson Lachlan H, Dottori Mirella
Murdoch Childrens Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia; Centre for Neural Engineering, Department of Electrical and Electronic Engineering, The University of Melbourne, Melbourne, Victoria, Australia.
Department of Otolaryngology, The University of Melbourne, Melbourne, Victoria, Australia.
PLoS One. 2014 Jul 7;9(7):e101718. doi: 10.1371/journal.pone.0101718. eCollection 2014.
Friedreich ataxia (FRDA) is an autosomal recessive disease characterised by neurodegeneration and cardiomyopathy that is caused by an insufficiency of the mitochondrial protein, frataxin. Our previous studies described the generation of FRDA induced pluripotent stem cell lines (FA3 and FA4 iPS) that retained genetic characteristics of this disease. Here we extend these studies, showing that neural derivatives of FA iPS cells are able to differentiate into functional neurons, which don't show altered susceptibility to cell death, and have normal mitochondrial function. Furthermore, FA iPS-derived neural progenitors are able to differentiate into functional neurons and integrate in the nervous system when transplanted into the cerebellar regions of host adult rodent brain. These are the first studies to describe both in vitro and in vivo characterization of FA iPS-derived neurons and demonstrate their capacity to survive long term. These findings are highly significant for developing FRDA therapies using patient-derived stem cells.
弗里德赖希共济失调(FRDA)是一种常染色体隐性疾病,其特征为神经退行性变和心肌病,由线粒体蛋白铁调素不足引起。我们之前的研究描述了保留该疾病遗传特征的FRDA诱导多能干细胞系(FA3和FA4 iPS)的产生。在此,我们扩展这些研究,表明FA iPS细胞的神经衍生物能够分化为功能性神经元,这些神经元对细胞死亡的易感性未改变,且具有正常的线粒体功能。此外,FA iPS来源的神经祖细胞在移植到成年宿主啮齿动物脑的小脑区域时,能够分化为功能性神经元并整合到神经系统中。这些是首次描述FA iPS来源神经元的体外和体内特征并证明其长期存活能力的研究。这些发现对于使用患者来源的干细胞开发FRDA治疗方法具有高度重要意义。